Skip to content

Quantitative T1rho Magnetic Resonance Imaging in Healthy Subjects

Quantitative T1rho Magnetic Resonance Imaging in Healthy Subjects

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04993196
Enrollment
30
Registered
2021-08-06
Start date
2021-08-01
Completion date
2028-01-31
Last updated
2026-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Magnetic Resonance Imaging

Brief summary

T1rho imaging is a new MRI technique that has strong potential in neuroimaging. This technique does not require exogenous contrast agents and has high spatial resolution. In this study we aim to characterise the normal appearance of T1rho in the brain parenchyma in healthy participants. T1rho values will be measured in normal brain structures.

Interventions

DIAGNOSTIC_TESTT1rho imaging

Magnetic Resonance Imaging using T1rho

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- Male and female volunteers greater than or equal to 18 years of age

Exclusion criteria

* Subjects with a contraindication to magnetic resonance imaging such as the presence of metallic implants, claustrophobia and pregnancy. * Subjects with previous severe allergic or anaphylactoid reaction to a gadolinium contrast agent, or contraindication to contrast gadolinium administration, such severe renal disease or acutely deteriorating renal function, who would be at risk of nephrogenic systemic fibrosis * Subjects who are unable to tolerate the scan without moving the head as a result of symptoms such as tremor, spasticity, involuntary movements and spasms, cognitive impairment, coughing, and shortness of breath.

Design outcomes

Primary

MeasureTime frameDescription
T1rho value in normal grey and white matter in healthy volunteersUp to 2 monthsT1rho value (measured on T1rho weighted MRI) in normal grey and white matter in healthy volunteers

Countries

Hong Kong

Contacts

CONTACTTiffany So
tiffanyso@cuhk.edu.hk+85235051035

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026